Search Results - "Bayle, A"

Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group by Mosele, F., Remon, J., Mateo, J., Westphalen, C.B., Barlesi, F., Lolkema, M.P., Normanno, N., Scarpa, A., Robson, M., Meric-Bernstam, F., Wagle, N., Stenzinger, A., Bonastre, J., Bayle, A., Michiels, S., Bièche, I., Rouleau, E., Jezdic, S., Douillard, J-Y., Reis-Filho, J.S., Dienstmann, R., André, F.

“…Next-generation sequencing (NGS) allows sequencing of a high number of nucleotides in a short time frame at an affordable cost. While this technology has been…”
Get full text

FIGHT against FGF/FGFR alterations: what are the next steps? by Bayle, A., Martin-Romano, P., Loriot, Y.

Get full text

Geolocalization of water-waves origin within water distribution networks using time reversal of first event detection by Guibert, R., Bayle, A., Plouraboué, F.

“…Drinking water distribution networks in urban areas are daily subject to fast propagating pressure waves resulting from routine operations. These water-hammer…”
Get full text

ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe by Bayle, A., Bonastre, J., Chaltiel, D., Latino, N., Rouleau, E., Peters, S., Galotti, M., Bricalli, G., Besse, B., Giuliani, R.

“…Access to biomolecular technologies has become an essential requirement to ensure optimal and timely treatment of patients with cancer. This study sought to…”
Get full text

Reply to the Letter to the Editor regarding 'Overcoming Barriers in Biomarker Testing' J. García-Foncillas et al by Bayle, A, Chaltiel, D, Latino, N, Rouleau, E, Peters, S, Galotti, M, Bricalli, G, Besse, B, Giuliani, R, Bonastre, J

Get more information

Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022 by Araujo, D., Greystoke, A., Bates, S., Bayle, A., Calvo, E., Castelo-Branco, L., de Bono, J., Drilon, A., Garralda, E., Ivy, P., Kholmanskikh, O., Melero, I., Pentheroudakis, G., Petrie, J., Plummer, R., Ponce, S., Postel-Vinay, S., Siu, L., Spreafico, A., Stathis, A., Steeghs, N., Yap, C., Yap, T.A., Ratain, M., Seymour, L.

“…In 2021, the Food and Drug Administration Oncology Center of Excellence announced Project Optimus focusing on dose optimization for oncology drugs. The…”
Get full text

Immunogenicity and safety of influenza vaccination in cancer patients receiving checkpoint inhibitors targeting PD-1 or PD-L1 by Bayle, A., Khettab, M., Lucibello, F., Chamseddine, A.N., Goldschmidt, V., Perret, A., Ropert, S., Scotté, F., Loulergue, P., Mir, O.

Get full text

Bamlanivimab + etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignancies by Pommeret, F., Colomba, J., Bigenwald, C., Laparra, A., Bockel, S., Bayle, A., Michot, J.-M., Hueso, T., Albiges, L., Tiberghien, P., Marot, S., Jary, A., Lacombe, K., Barlesi, F., Griscelli, F., Colomba, E.

Get full text

Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group by Mosele, M F, Westphalen, C B, Stenzinger, A, Barlesi, F, Bayle, A, Bièche, I, Bonastre, J, Castro, E, Dienstmann, R, Krämer, A, Czarnecka, A M, Meric-Bernstam, F, Michiels, S, Miller, R, Normanno, N, Reis-Filho, J, Remon, J, Robson, M, Rouleau, E, Scarpa, A, Serrano, C, Mateo, J, André, F

“…Advancements in the field of precision medicine have prompted the European Society for Medical Oncology (ESMO) Precision Medicine Working Group to update the…”
Get more information

Clinical utility of circulating tumor DNA sequencing with a large panel: a National Center for Precision Medicine (PRISM) study by Bayle, A., Belcaid, L., Aldea, M., Vasseur, D., Peyraud, F., Nicotra, C., Geraud, A., Sakkal, M., Seknazi, L., Cerbone, L., Blanc-Durand, F., Hadoux, J., Mosele, F., Tagliamento, M., Bernard-Tessier, A., Verret, B., Smolenschi, C., Clodion, R., Auger, N., Romano, P.M., Gazzah, A., Camus, M.N., Micol, J., Caron, O., Hollebecque, A., Loriot, Y., Besse, B., Lacroix, L., Rouleau, E., Ponce, S., Soria, J.C., Barlesi, F., Andre, F., Italiano, A.

“…Circulating tumor DNA (ctDNA) sequencing is a promising approach for tailoring therapy in patients with cancer. We report hereby the results from a prospective…”
Get full text

Liquid versus tissue biopsy for detecting actionable alterations according to the ESMO Scale for Clinical Actionability of molecular Targets in patients with advanced cancer: a study from the French National Center for Precision Medicine (PRISM) by Bayle, A., Peyraud, F., Belcaid, L., Brunet, M., Aldea, M., Clodion, R., Dubos, P., Vasseur, D., Nicotra, C., Geraud, A., Sakkal, M., Cerbone, L., Blanc-Durand, F., Mosele, F., Martin Romano, P., Ngo Camus, M., Soubeyran, I., Khalifa, E., Alame, M., Blouin, L., Dinart, D., Bellera, C., Hollebecque, A., Ponce, S., Loriot, Y., Besse, B., Lacroix, L., Rouleau, E., Barlesi, F., Andre, F., Italiano, A.

Get full text

Patients’ selection and trial matching in early-phase oncology clinical trials by Corbaux, P., Bayle, A., Besle, S., Vinceneux, A., Vanacker, H., Ouali, K., Hanvic, B., Baldini, C., Cassier, P.A., Terret, C., Verlingue, L.

“…Early-phase clinical trials (EPCT) represent an important part of innovations in medical oncology and a valuable therapeutic option for patients with…”
Get full text

Severe COVID-19 in patients with hematological cancers presenting with viremia by Michot, J.M., Hueso, T., Ibrahimi, N., Pommeret, F., Willekens, C., Colomba, E., Francis, S., Bayle, A., Cournède, P.H., Merad, M., Foulon, S., Albiges, L., Gachot, B., Barlesi, F., Soria, J.C., Ribrag, V., Griscelli, F.

Get full text

Detection of additional occult malignancy through profiling of ctDNA in late-stage cancer patients by Aldea, M., Cerbone, L., Bayle, A., Parisi, C., Sarkozy, C., Vasseur, D., Verlingue, L., Blanc-Durand, F., Mosele, F., Sakkal, M., Ponce, S., Lavaud, P., Loriot, Y., Hollebecque, A., Massard, C., Soria, J.-C., Lacroix, L., Rouleau, E., Italiano, A.

Get full text

Prevention of chemotherapy-induced nausea and vomiting in patients receiving ifosfamide: High dose chemotherapy by Talarmin, C, Herpin, C, Bayle, A, Fayard, C, Le Cesne, A, Mir, O, Lemare, F, Paret, A, Netzer, F

Get full text

The role of acrylophosphonic acid monomers in the formation of hybrid layers based on self-etch adhesives by Bayle, Marie A, Grégoire, Geneviève, Sharrock, Patrick

“…Abstract The role of acrylophosphonic acid monomers in the formation of hybrid layers based on self-etch adhesives. Objectives Our plan was to define the…”
Get full text

s -Heptazine oligomers: promising structural models for graphitic carbon nitride by Zambon, A, Mouesca, J-M, Gheorghiu, C, Bayle, P A, Pécaut, J, Claeys-Bruno, M, Gambarelli, S, Dubois, L

“…Graphitic carbon nitride (g-CN) has interesting catalytic properties but is difficult to study due to its structure and how it is produced. In this study,…”
Get full text

Modeling the transition state structure to probe a reaction mechanism on the oxidation of quinoline by quinoline 2-oxidoreductase by Bayle, Enyew A.

“…Background Quinoline 2-oxidoreductase (Qor) is a member of molybdenum hydroxylase which catalyzes the oxidation of quinoline (2, 3 benzopyridine) to…”
Get full text

Acrylophosphonic acid reactivity with calcium ions and biological apatite by Bayle, Marie A, Nasr, Karim, Grégoire, Geneviève, Sharrock, Patrick

“…Abstract Objectives Acrylophosphonic acid (H2 L) was reacted with biological apatite originating from dental enamel powder in order to identify and study the…”
Get full text

Retrograde aortic dissection after a stent graft repair of a type B dissection: how to improve the endovascular technique by Rubin, Sylvain, Bayle, Aurelie, Poncet, Anne, Baehrel, Bernard

“…CHU Reims, Hôpital Robert Debré, Service de Chirurgie Thoracique et Cardio-Vasculaire, F-51092, Reims, France *Corresponding author. Service de Chirurgie…”
Get full text